Filing Details
- Accession Number:
- 0001140361-15-034271
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-02 20:04:53
- Reporting Period:
- 2015-08-31
- Filing Date:
- 2015-09-02
- Accepted Time:
- 2015-09-02 20:04:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070698 | Raptor Pharmaceutical Corp | RPTP | Pharmaceutical Preparations (2834) | 860883978 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1362489 | Raymond Anderson | C/O Raptor Pharmaceutical Corp. 7 Hamilton Landing, Suite 100 Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-31 | 8,084 | $2.02 | 14,779 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-08-31 | 8,084 | $12.52 | 6,695 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock options (right to buy) | Disposition | 2015-08-31 | 8,084 | $0.00 | 8,084 | $2.02 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,916 | 2020-03-09 | No | 4 | M | Direct |
Footnotes
- Includes 5021 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof. The RSUs will vest in full on the first anniversary of the date of grant.
- This transaction was executed in multiple trades at prices ranging from $12.50 to $12.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Fully vested and exercisable.